Streetbeat News

Stock Prices

ASTS

AST Space Mobile is reportedly planning a share offering priced between $3.00 and $3.50, according to a source.

Portfolio Pulse from Charles Gross

January 18, 2024 | 10:07 pm

ASTS

GOOG

GOOGL

AST SpaceMobile Inc (NASDAQ:ASTS) experienced volatility after announcing a $155 million strategic investment from AT&T Inc (NYSE:T), Alphabet Inc (NASDAQ:GOOG) (NASDAQ:GOOGL), and Vodafone, followed by a $100 million common stock offering. The investment aims to support the commercial rollout of AST SpaceMobile's network, with the new investors also expanding strategic and commercial ties. The stock surged in after-hours trading but pulled back after the stock offering announcement.

Portfolio Pulse from Adam Eckert

January 18, 2024 | 9:59 pm

META

NVDA

Mark Zuckerberg, CEO of Meta Platforms Inc. (META), announced the company's major AI initiatives, focusing on integrating AI research efforts, developing general intelligence, committing to open-source technology, and investing in infrastructure with Nvidia Corp. (NVDA) GPUs. Meta is working on projects like Llama 3 and plans to integrate AI into new devices such as glasses. Following the announcement, META shares rose 2.1%, nearing all-time highs.

Portfolio Pulse from Piero Cingari

January 18, 2024 | 9:45 pm

DTSS

Datasea Inc. has announced a 1-for-15 reverse stock split to regain compliance with Nasdaq's minimum bid requirement. The reverse stock split is scheduled to take effect on January 19, 2024, with split-adjusted trading under the symbol 'DTSS' starting on January 23, 2024.

Portfolio Pulse from Benzinga Newsdesk

January 18, 2024 | 9:42 pm

ADTX

Aditxt, Inc. has disclosed in a filing that a selling stockholder is offering up to 3.8 million shares of common stock on a resale basis. This indicates that existing shares are being sold by a stockholder, rather than the company issuing new shares.

Portfolio Pulse from Benzinga Newsdesk

January 18, 2024 | 9:36 pm

FNB

F N B Corporation (NYSE:FNB) reported Q4 earnings with an EPS of $0.38, beating estimates by 8.57% but with a revenue decrease from the previous year. The company has a history of surpassing EPS estimates, which has sometimes led to a slight increase in share price the following day.

Portfolio Pulse from Benzinga Insights

January 18, 2024 | 9:35 pm

SPY

Goldman Sachs CEO David Solomon expressed skepticism at Davos about the market's expectation of seven rate cuts in 2024, suggesting that the likelihood of such cuts is lower than previously thought. Despite this, he doesn't foresee a major market correction. The SPDR S&P 500 ETF (SPY) has seen a modest increase this year after a significant rally in 2023.

Portfolio Pulse from Erica Kollmann

January 18, 2024 | 9:31 pm

WEN

Wendy's has announced the appointment of Kirk Tanner as President and CEO, effective February 5, 2024. This leadership change is significant for the company's future direction and strategy.

Portfolio Pulse from Benzinga Newsdesk

January 18, 2024 | 9:31 pm

EJH

INSE

LAZR

SFIX

SVMH

VMAR

VRM

In Thursday's after-market session, several consumer discretionary stocks experienced movement. SRIVARU Holding (SVMH) led the gainers with a 6.0% increase, while Inspired Entertainment (INSE) saw the largest decline among the losers, dropping 7.5%. Other notable movers included E-Home Household Service (EJH), Vision Marine (VMAR), Stitch Fix (SFIX), Luminar Technologies (LAZR), and Vroom (VRM). On the losing side, Chijet Motor Co (CJET), MGO Global (MGOL), Brilliant Earth Group (BRLT), and Cenntro Electric Gr (CENN) also saw their stock prices fall.

Portfolio Pulse from Benzinga Insights

January 18, 2024 | 9:31 pm

CHRS

CNSP

ESPR

IONM

RBOT

SHPH

In Thursday's after-market session, several healthcare stocks experienced significant movements. Assure Holdings (IONM) and Shuttle Pharmaceuticals (SHPH) were among the gainers, with stocks rising 13.3% and 10.24%, respectively. Coherus BioSciences (CHRS) and Vicarious Surgical (RBOT) also saw their shares increase. On the losing side, Esperion Therapeutics (ESPR) and CNS Pharma (CNSP) experienced declines in their stock prices by 16.8% and 6.18%, respectively. Other losers included Alaunos Therapeutics (TCRT), Windtree Therapeutics (WINT), Jaguar Health (JAGX), and Ainos (AIMD).

Portfolio Pulse from Benzinga Insights

January 18, 2024 | 9:31 pm